Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pyke

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Anaesthesia and Intensive Care|August 10, 2011
Anaphylaxis and patent Blue VC Pyke
The Australian and New Zealand Journal of Surgery|June 1, 1996
Prognostic factors and the curability of breast cancerC Pyke
Breast Cancer Research and Treatment|January 1, 1993
Type IV collagenases in invasive tumorsK Tryggvason, M Höyhtyä, C Pyke
International Journal of Cancer|September 15, 1995
Expression of urokinase receptor in various stromal-cell populations in human colon cancer: immunoelectron microscopical analysisH Ohtani, C Pyke, K Danø, et al.
The American Journal of Pathology|February 1, 1993
Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancerC Pyke, E Ralfkiaer, K Tryggvason, et al.
Histochemistry|January 1, 1989
Plasminogen activator inhibitor (type-1) in rat adrenal medullaJ Eriksen, P Kristensen, C Pyke, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 1997
Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistryH Pappot, B G Skov, C Pyke, et al.
Cancer Research|August 1, 1991
The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stromaC Pyke, P Kristensen, E Ralfkiaer, et al.
Annals of the New York Academy of Sciences|December 4, 1992
The urokinase receptor: involvement in cell surface proteolysis and cancer invasionV Ellis, C Pyke, J Eriksen, et al.
Blood|March 10, 2001
Tissue factor-mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factorC B Hansen, C Pyke, L C Petersen, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Anaesthesia and Intensive Care|August 10, 2011
Anaphylaxis and patent Blue VC Pyke
The Australian and New Zealand Journal of Surgery|June 1, 1996
Prognostic factors and the curability of breast cancerC Pyke
Breast Cancer Research and Treatment|January 1, 1993
Type IV collagenases in invasive tumorsK Tryggvason, M Höyhtyä, C Pyke
International Journal of Cancer|September 15, 1995
Expression of urokinase receptor in various stromal-cell populations in human colon cancer: immunoelectron microscopical analysisH Ohtani, C Pyke, K Danø, et al.
The American Journal of Pathology|February 1, 1993
Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancerC Pyke, E Ralfkiaer, K Tryggvason, et al.
Histochemistry|January 1, 1989
Plasminogen activator inhibitor (type-1) in rat adrenal medullaJ Eriksen, P Kristensen, C Pyke, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 1997
Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistryH Pappot, B G Skov, C Pyke, et al.
Cancer Research|August 1, 1991
The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stromaC Pyke, P Kristensen, E Ralfkiaer, et al.
Annals of the New York Academy of Sciences|December 4, 1992
The urokinase receptor: involvement in cell surface proteolysis and cancer invasionV Ellis, C Pyke, J Eriksen, et al.
Blood|March 10, 2001
Tissue factor-mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factorC B Hansen, C Pyke, L C Petersen, et al.
Pageof 5